Esperion Presents Results from New Analysis on Cardiovascular Benefits with Bempedoic Acid Treatment at ENDO 2023GlobeNewsWire • 06/15/23
Why Is Esperion Therapeutics (ESPR) Down 6.9% Since Last Earnings Report?Zacks Investment Research • 06/08/23
Esperion to Present New Key Science at the American Diabetes Association's 83rd Scientific Sessions 2023GlobeNewsWire • 06/08/23
Esperion Therapeutics (ESPR) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 04/25/23
Top 5 Health Care Stocks That Preparing To Pump This Quarter - Enovis (NYSE:ENOV), Esperion Therapeutics (NASDAQ:ESPR)Benzinga • 03/29/23
Esperion Announces Closing of $56.7 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesGlobeNewsWire • 03/22/23
Esperion Therapeutics stock slumps 22% premarket as data from study of cholestrol-lowering drug fail to impress investorsMarket Watch • 03/06/23